BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4463033)

  • 1. [Quality control of prepared drug forms containing corticosteroids by physicochemical means. II. Spectrophotmetric determination of prednisolone and fluocinolone acetonide in ointments].
    Bobkova LN; Kazarinov NA
    Farm Zh; 1974; (1):59-63. PubMed ID: 4463033
    [No Abstract]   [Full Text] [Related]  

  • 2. [Quality control by physicochemical methods of prepared drug forms containing corticosteroids. I. The spectrophotometric determination of hydrocortisone acetate in an ointment].
    Bobkova LN; Kazarinov NA
    Farm Zh; 1973; 28(6):29-33. PubMed ID: 4792450
    [No Abstract]   [Full Text] [Related]  

  • 3. [Determination and identification of fluocinolone acetonide in dermatological ointments].
    Cosi G; Bichi GL
    Farmaco Prat; 1970 Apr; 25(4):248-52. PubMed ID: 5419462
    [No Abstract]   [Full Text] [Related]  

  • 4. [Determination of fluocinolone acetonide in a dermatologic cream using differential UV spectrophotometry].
    Coda L; Timallo L
    Boll Chim Farm; 1976 Jul; 115(7):515-20. PubMed ID: 1016607
    [No Abstract]   [Full Text] [Related]  

  • 5. Determination of fluocinolone acetonide in pharmaceutical preparations by differential-pulse polarography.
    Leung CP; Tam SY
    Analyst; 1981 Jan; 106(1258):100-4. PubMed ID: 7469025
    [No Abstract]   [Full Text] [Related]  

  • 6. Distribution of fluocinolone acetonide in oil-in-water creams and its release from the creams.
    Takashima Y; Tanaka S; Yoshizawa H
    Chem Pharm Bull (Tokyo); 1983 Nov; 31(11):4040-7. PubMed ID: 6671242
    [No Abstract]   [Full Text] [Related]  

  • 7. The quantitative determination of fluocinolone acetonide and acetonide acetate in formulated products by high pressure liquid chromatography.
    Bailey F; Brittain PN
    J Pharm Pharmacol; 1972 Jun; 24(6):425-8. PubMed ID: 4403822
    [No Abstract]   [Full Text] [Related]  

  • 8. Steroid determination from complex mixtures by high pressure chromatographic techniques.
    Landgraf WC; Jennings EC
    J Pharm Sci; 1973 Feb; 62(2):278-81. PubMed ID: 4346815
    [No Abstract]   [Full Text] [Related]  

  • 9. A new corticoid for topical therapy. Fluocinolone acetonide.
    SCHOLTZ JR
    Calif Med; 1961 Oct; 95(4):224-6. PubMed ID: 13909153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. THERAPEUTIC EFFICACY OF FLUOCINOLONE ACETONIDE OINTMENT AND CREAM.
    BLEIBERG J; BRODKIN RH
    Arch Dermatol; 1964 Apr; 89():561. PubMed ID: 14107624
    [No Abstract]   [Full Text] [Related]  

  • 11. CLINICAL EVALUATION OF TOPICAL FLUOCINOLONE ACETONIDE OINTMENT.
    SCHER RK
    Curr Ther Res Clin Exp; 1963 Dec; 5():626-7. PubMed ID: 14084033
    [No Abstract]   [Full Text] [Related]  

  • 12. [THERAPY OF VARIOUS TYPES OF ECZEMA WITH FLUOCINOLONE ACETONIDE HYDROPHILIC OINTMENT].
    FUKUHARA M; SONODA S
    Hifuka Kiyo; 1963 Mar; 58():103-5. PubMed ID: 14045192
    [No Abstract]   [Full Text] [Related]  

  • 13. FLUOCINOLONE ACETONIDE IN AN OINTMENT BASE: A CLINICAL EVALUATION.
    DICK LA
    Skin (Los Angeles); 1963 Dec; 2():371-3. PubMed ID: 14088565
    [No Abstract]   [Full Text] [Related]  

  • 14. EXPERIENCE WITH TOPICAL FLUOCINOLONE ACETONIDE OINTMENT IN PSORIASIS.
    SCHIFF B; KERN AB
    R I Med J; 1963 Oct; 46():534-6. PubMed ID: 14053804
    [No Abstract]   [Full Text] [Related]  

  • 15. [TREATMENT OF PSORIASIS WITH FLUOCINOLONE ACETONIDE. PERSONAL OBSERVATIONS].
    ESCALONA E
    Medicina (Mex); 1964 May; 44():199-203. PubMed ID: 14151306
    [No Abstract]   [Full Text] [Related]  

  • 16. Decrease of urinary corticosteroids following application of fluocinolone acetonide under an occlusive dressing.
    SCOGGINS RB
    J Invest Dermatol; 1962 Dec; 39():473-4. PubMed ID: 13992475
    [No Abstract]   [Full Text] [Related]  

  • 17. Relative potency of percutaneously absorbed corticosteroids in the suppression of pituitary-adrenal function.
    Scoggins RB; Kliman B
    J Invest Dermatol; 1965 Nov; 45(5):347-55. PubMed ID: 5321337
    [No Abstract]   [Full Text] [Related]  

  • 18. [THERAPEUTIC TRIAL OF AN 0.01 P. 100 FLUOCINOLONE ACETONIDE OINTMENT UNDER HERMETIC DRESSINGS IN PSORIASIS].
    TEMIME P; PRIVAT Y; BURNOD A; LATOURELLE P
    Bull Soc Fr Dermatol Syphiligr; 1963; 70():915-6. PubMed ID: 14159326
    [No Abstract]   [Full Text] [Related]  

  • 19. [TREATMENT OF PSORIASIS WITH FLUOCINOLONE ACETONIDE 0.01 PER CENT BY THE OCCLUSIVE METHOD].
    MILLANGUTIERREZ J
    Medicina (Mex); 1964 Mar; 44():111-4. PubMed ID: 14138600
    [No Abstract]   [Full Text] [Related]  

  • 20. [CORTICOSTEROID DRUGS AND CUTANEOUS REACTIVITY. EXPERIMENTAL RESEARCH. I. TOPICAL CORTICOSTEROIDS AND PHARMACODYNAMIC REACTION].
    MARTINA G; GRASSO R
    Minerva Dermatol; 1965 Jan; 40():18-21. PubMed ID: 14306915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.